mortality/aging
• age-dependent reduction in survival due to tonic-clonic seizures
|
nervous system
• around 3 months of age, mice show spontaneous epileptic seizures; animals affected and seizure number per animal increase with age
• mutants show reduced latency to seizure onset and tendency to have stronger seizures when treated with kainic acid or PTZ than wild-type; seizure-induced lethality is greatly increased
• blockade of cannabinoid receptors does not result in aggravation of kainic acid-induced seizures in mutants but does in wild-type controls
• treatment of mutants with endocannabinoid reuptake inhibitor causes a significant amelioration of kainic acid induced seizures
|
• most seizures are myoclonic
|
• some animals exhibit tonic-clonic seizures with age
|
• older animals particularly those with symptomatic epilepsy show neuronal degeneration in CA1 region
|
• no CCK4-induced (cholecystokinin receptor2 agonist) current is detected in amygdala slices while inward current response in wild-type is unaffected
|
behavior/neurological
• around 3 months of age, mice show spontaneous epileptic seizures; animals affected and seizure number per animal increase with age
• mutants show reduced latency to seizure onset and tendency to have stronger seizures when treated with kainic acid or PTZ than wild-type; seizure-induced lethality is greatly increased
• blockade of cannabinoid receptors does not result in aggravation of kainic acid-induced seizures in mutants but does in wild-type controls
• treatment of mutants with endocannabinoid reuptake inhibitor causes a significant amelioration of kainic acid induced seizures
|
• most seizures are myoclonic
|
• some animals exhibit tonic-clonic seizures with age
|